Tomorrow, the healthcare marketplaces open for business, and in 8 days, their long-term destiny will be clearer as the race for the White House is settled. This is the fourth…
“Value” is the most important concept in healthcare today. But it’s problematic. Futurists say our system is transitioning from volume to value. Device and drug manufacturers tout the value of…
In Campaign 2016, a recurring theme to date has been the trustworthiness of the leading candidates. As they debate for the third and final time this week, each will attempt…
I participate in hospital strategic planning retreats frequently. Routinely, the question is asked: what’s our future? Though the pace of change is quickening and markets vary, the destination seems clear….
Last Wednesday, 179 members of the House of Representatives sent notice to CMS Acting Administrator Andy Slavitt and Chief Medical Officer Patrick Conway that they’re not happy about Medicare’s decision…
The great debate is tonight. In 2012, 67 million tuned in to see how challenger Mitt Romney and would fare against the incumbent Barack Obama. Tonight, it’s the much anticipated…
Legendary radio commentator Paul Harvey ended his daily report with a final story introduced by the tease “Now for the rest of the story.” Last Tuesday, the U.S. Census Bureau…
Today is my birthday: I am 67. That means I am an old fart with all the rights and privileges bestowed. I get a pass for untrimmed nose hair, occasional…
When I was 11, a sixth grader at Henry L. Barger Elementary in Chattanooga, Tennessee, my life changed. It was 1960. Jerry Myrick, my best buddy, asked me to play…
News about soaring drug prices rival health insurance premium increases for media attention to healthcare these days. Mylan Pharmaceuticals’ 461% price increase (2007-2014) for its EpiPens is the latest call-out…
Stay informed with Paul’s unique perspective on healthcare happenings, from policies and politics to innovations and investments. Subscribe today to the Keckley Report and be the first to receive Paul’s weekly insights and special reports.
© 2024 Paul Keckley.
